Delivery Order SPE2DB20D2104-SPE2DB25FMRFR
Award Date
5/19/25
Potential Completion Date
5/20/25
Potential Value
$3.3K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is for the delivery of budesonide-formoterol 160-4.5 10.2GM pharmaceutical products to the Defense Logistics Agency (DLA), a defense agency. The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, for a firm fixed price of $4,586.62. The award has an ultimate completion date of May 21, 2025. This contract is not set aside and is part of a larger Indefinite Delivery Contract (IDC) valued at...
This federal contract award is for the delivery of Budesonide-Formoterol 160-4.5 10.2GM, a pharmaceutical product, to the Defense Logistics Agency (DLA). The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, on November 5, 2024, with a ceiling value of $1,641.57 and an ultimate completion date of November 6, 2024. This is a firm fixed-price delivery order contract with no set-aside designation, indicating open...
This federal contract award is for the delivery of Budesonide-Formoterol 160-4.5 10.2GM pharmaceutical products to the Defense Logistics Agency (DLA). The contract, valued at $1,460.46, was awarded to Amerisourcebergen Drug Corp's Corporate Office Division, a major supplier of pharmaceutical products and medical supplies to the U.S. federal government, particularly the Department of Defense (DoD) and Veterans Affairs (VA) healthcare systems. The contract is a delivery order under...
This federal contract award is for the delivery of Budesonide-Formoterol 80-4.5 10.2GM pharmaceutical products to the Defense Logistics Agency (DLA), a defense agency of the U.S. government. The contract, valued at $1,748.60, was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distribution company, on May 7, 2024, with a completion date of May 8, 2024. The contract is a Delivery Order with a Firm Fixed Price pricing type. There is no set-aside designation for this award....
This federal contract award, issued by the Defense Logistics Agency (DLA), is a delivery order with a firm fixed price valued at $2,921.57. The award is for the procurement of Budesonide-Formoterol 160-4.5 10.2GM, a pharmaceutical product, with a completion date of February 6, 2025. The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. This contract is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999...
This federal contract award is for the delivery of Budesonide-Formoterol 160-4.5 10.2GM, a pharmaceutical product, to the Defense Logistics Agency (DLA) under contract SPE2DB20D2002|SPE2DB24FL43R. The contract has a ceiling value of $1,663.71 and is a Firm Fixed Price Delivery Order. The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. This contract is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that...
This federal contract award is to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, for the delivery of budesonide-formoterol 160-4.5 10.2GM. The contract is a delivery order with a firm fixed price of $3,840.42 and has an ultimate completion date of November 25, 2024. The contracting agency is the Defense Logistics Agency (DLA), a defense agency responsible for providing logistics, acquisition, and technical services to the U.S. Armed Forces....
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,289.97 delivery order contract is for the delivery of budesonide-formoterol 160-4.5 10.2 gram medication. The contract has a firm fixed price pricing type and an ultimate completion date of July 25, 2024. It is associated with a larger $999,999,999 Indefinite Delivery Contract (IDC) that AmerisourceBergen holds...
This federal contract award is for the delivery of Budesonide-Formoterol 80-4.5 10.2GM pharmaceutical products to the Defense Logistics Agency (DLA). The contract, valued at $1,590.90, was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of...
This federal contract award, valued at $1,372.04, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Budesonide-Formoterol 160-4.5 10.2GM, a pharmaceutical product, with a completion date of February 20, 2025. The contract is a Delivery Order under a Firm Fixed Price structure, and there was no set-aside designation used. AmerisourceBergen holds a significant...